Cipla Health Ltd., one of India's most trusted fast-moving wellness goods (FMWG) companies, has announced the launch of ...

Chennai: Cipla Health, a leading player in consumer healthcare, announced the launch of its latest campaign, "Cipladine – Aapka Fast Aid Expert," featuring acclaimed actress Neena Gupta as the brand ...

Lowe Lintas crafts Cipladine’s new campaign highlighting its fast action and reliability, repositioning it as a ‘Fast Aid’ solution for everyday injuries ...

Novo Nordisk launches weightloss drug Wegovy in India at competitive prices, facing patent battles and high demand.

Deven Choksey, MD of DRChoksey FinServ, says private sector insurance companies are relatively more favourable from a growth perspective. Valuation-wise, some of them have already started scaling up.

Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG FORCE Walk, reaffirming its commitment to advancing respiratory health ...

Cipla is likely to see a block trade of shares worth Rs 2,637 crore on May 15, with the promoter family and Okasa Pharma selling as much as 2.53 percent stake. CNBC-Awaaz was the first to report ...

With Cipla's shares showing a gain of 0.55% to reach Rs 1,481.30, the stock reflects ongoing market activity in the pharmaceutical sector.

Cipla delivered better-than-expected results, supported by strong traction in the US, One Africa, and EM/EU regions. Coal India reported higher other income, contributing to its outperformance.

Cipla Ltd has announced that the United States Food and Drug Administration (USFDA), has recently completed cGMP inspection at company’s Bommasandra manufacturing facility in Bengaluru. The ...